 send to a friend by email
2024-11-12
According to the financial statements of Birzeit Pharmaceuticals BPC for the first nine months of 2024, Net profit after tax of the period reached 2,255,871 USD Compared with Net profit after tax 4,813,152 USD for 2023, a net decrease in profit of 53.13%.Total assets of the company reached 121,511,178 USD compared with total assets of 125,146,969 USD at the end of year 2023, a net decrease of 2.91%.Total liabilities of the company reached 21,813,286 USD compared with total liabilities of 20,122,207 USD at the end of year 2023, a net increase of 8.40%. Net ownership equity of the company reached 99,697,892 USD (Including Non-Controlling Interests of 712,001 USD) compared with total owner equity of 105,024,762 USD (Including Non-Controlling Interests of 700,373 USD) at the end of year 2023, a net decrease of 5.07%.
|
-trade
